Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance
BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today provides...